Abstract

Postpartum depression affects 10-15% of women. Novel evidence suggests that genomic markers for enhanced sensitivity to estradiol signaling may help identify women at high risk of postpartum depression. We explored the women's perceptions of testing for genomic risk markers for developing postpartum depression.